Infliximab

Details

Files
Generic Name:
Infliximab
Project Status:
Complete
Therapeutic Area:
Crohn’s disease and Ulcerative Colitis
Manufacturer:
Hospira HealthCare Corporation, a Pfizer Company
Call for patient/clinician input open:
Brand Name:
Inflectra (Subsequent Entry Biologic)
Project Line:
Reimbursement Review
Project Number:
SE0483-000
Call for patient/clinician input closed:
Submission Type:
Initial
Indications:
Crohn’s disease and Ulcerative Colitis
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: